Apogee Therapeutics, Inc.
Apogee Therapeutics, Inc. (APGE) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
apge · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Apogee Therapeutics, Inc. (APGE) measures how much investors pay for each dollar of the company's trailing earnings. APGE's current PE ratio of N/A is calculated by dividing its stock price of $83.12 by its TTM earnings per share of -$3.94.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2022 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Apogee Therapeutics, Inc.You APGE | $5.1B | N/A | — | -$3.94 |
 Ascentage Pharma Group International AAPG | $1.6B | N/A | — | -$13.58 |
 Celcuity Inc. CELC | $4.3B | N/A | — | -$3.37 |
 CG Oncology, Inc. Common stock CGON | $4.8B | N/A | — | -$2.08 |
 Centessa Pharmaceuticals plc CNTA | $6.1B | N/A | — | -$1.46 |
 Disc Medicine, Inc. IRON | $2.5B | N/A | — | -$6.01 |
 Legend Biotech Corporation LEGN | $5.8B | N/A | — | -$1.61 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-4.22 | — | |
2024-12-31 FY2024 | — | $-3.30 | — | |
2023-12-31 FY2023 | — | $-1.66 | — | |
2022-12-31 FY2022 | — | $-0.79 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Apogee Therapeutics, Inc. (APGE) measures how much investors pay for each dollar of the company's trailing earnings. APGE's current PE ratio of N/A is calculated by dividing its stock price of $83.12 by its TTM earnings per share of -$3.94.
Frequently asked questions
APGE pe ratio · 6 questionsAPGE's current PE ratio is N/A as of 2026-06-08, based on a stock price of $83.12 and TTM EPS of -$3.94. Data sourced from Financial Modeling Prep via APGE's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Apogee Therapeutics, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08